Article

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

2018-09-18

Abstract excerpt

<h4>Background: </h4> Xpert® MTB/RIF, a rapid tuberculosis (TB) molecular test, was endorsed by the World Health Organization in 2010. Since then, 34.4 million cartridges have been procured under concessional pricing. Although the roll out of this diagnostic is promising, previous studies showed low market penetration. <h4>Methods: </h4>: To assess 3-year trends of market penetration of Xpert MTB/RIF in the publi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7b236094-3efb-5b84-92c2-8e72de327756
DOI: 10.12688/gatesopenres.12842.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016DOI 10.12688/gatesopenres.12842.2Read

Challenges with Scale-up of GeneXpert MTB/RIF® inUganda: a Health Systems PerspectiveSemantic proximity Read

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriersSemantic proximity Read

Evaluation of GeneXpert® in Brazil Through a Historical and Epidemiological ApproachSemantic proximity Read

Total Quality Management of GeneXpert-Based Tuberculosis Testing in Hospitals in Greater Accra, GhanaSemantic proximity Read

Use of rapid molecular tuberculosis diagnostics across Brazil’s incarcerated populationSemantic proximity Read

Integrated Use of the GeneXpert Platform for TB, HIV and EVD testing in LiberiaSemantic proximity Read

Access the Diagnostic Accuracy of GeneXpert to Detect <em>Mycobacterium tuberculosis</em> and Rifampicin-Resistance Tuberculosis among Presumptive Tuberculosis and Presumptive Drug Resistant Tuberculosis PatientsSemantic proximity Read

Improving testing capacity for COVID-19: Experiences and lessons from Senegal, Uganda, Nigeria and the Democratic Republic of CongoSemantic proximity Read

Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of rapid molecular testing in a city in south-eastern BrazilSemantic proximity Read

Detection and Frequency of Mycobacterium tuberculosis and Rifampicin Resistance Among Patients Attending the National TB Control Program in Sana'a, Yemen Using Xpert- MTB/RIF AssaySemantic proximity Read

Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013.Semantic proximity Read

Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy studySemantic proximity Read